Chronic traumatic encephalopathy is rare in high school football players, but not zero: in the largest published brain-bank series, about 3 percent of donated brains from athletes who played only through high school showed CTE. That figure describes donated brains, not the living population of teenage players, and the gap between those two numbers is the heart of this topic. Understanding why requires looking at what CTE is, how it is detected, and who ends up in the samples researchers study.

The mechanism: what CTE does to brain tissue

CTE is a neurodegenerative tauopathy. In susceptible people, repeated mechanical injury to the head triggers abnormal phosphorylation of the tau protein, which normally stabilizes microtubules inside neurons. The phosphorylated tau clumps into tangles that aggregate in neurons and astrocytes, and the aggregates spread in a characteristic pattern.

The pattern matters for diagnosis. CTE lesions cluster around small blood vessels at the depths of cortical sulci and in the amygdala, hippocampus, and brainstem. That perivascular, sulcal-depth distribution is what distinguishes CTE from Alzheimer's disease pathologically. In Alzheimer's, tangles follow a different spread sequence through the medial temporal lobe and association cortex.

Why would adolescent brains be vulnerable at all? Animal and human data suggest the developing brain has less myelination and different biomechanical properties than the adult brain, and animal models show immature axons are more susceptible to stretch injury. A single season of high school football has been shown in neuroimaging studies to produce measurable changes in white matter microstructure, though those changes are usually transient and different from CTE pathology. The key mechanistic point: CTE is associated with cumulative repetitive head impact exposure over years, not with one concussion. A player who sustains a single concussion but no repetitive subconcussive exposure does not fit the mechanistic profile. A player with years of lineman-level repetitive impacts fits it better, even if he never reports a concussion.

Quantified context: what the numbers say

The best-known dataset is the Boston University brain bank, which reported in 2019 on 63 donated brains from males who played football no higher than high school. Of those, two had CTE, roughly 3 percent. The same series found that among 208 high school players whose brains were donated, 21 (about 10 percent) had CTE. The different denominators reflect different case definitions in the reporting; treat the range as roughly 3 to 10 percent of donated high school-only brains, not a single precise figure.

Two caveats frame those percentages. First, brain bank donors are not representative. Families often donate after a player develops symptoms, which inflates prevalence relative to the general population of former players. Second, the comparison groups matter: in the same BU series, over 60 percent of donated brains from professional players showed CTE, and the increase across levels of play was dose-dependent.

What about living populations? There is no validated test for CTE in living people, so no true prevalence figure exists for any group, including high school players. Current estimates rely on autopsy. A 2023 consensus statement from the National Institute of Neurological Disorders and Stroke described CTE as a delayed-onset disorder and cautioned that the frequency in the general population is unknown. That absence of a population denominator is why headline percentages from brain banks must be read carefully.

Here is the plain-language version: for every 100 families who donate a high school player's brain after concerning symptoms, roughly 3 to 10 have shown CTE. We do not know what that means for the thousands of players who never donate a brain and never show symptoms.

Timeline table: when pathology and symptoms appear

Time point What is known
During adolescence Repetitive impacts accumulate; no CTE-specific symptoms are identifiable in real time
Early adulthood (20s) Most former high school-only players remain asymptomatic; pathology, if present, is often incidental at autopsy
2 to 10 years after play Some former players report mood, behavior, or cognitive changes; these overlap with many other causes
Midlife (40s-50s) CTE symptoms, when they occur, typically emerge decades after exposure, including in some high school-only cases
After death Definitive diagnosis requires postmortem tissue examination using consensus neuropathological criteria
Aging cohort Comorbid Alzheimer's, vascular disease, and substance use complicate attribution of symptoms to CTE alone

Edge cases and the counterintuitive detail

The counterintuitive finding is that duration of play does not perfectly predict pathology. Some brains from long-career professional players show minimal CTE, and some high school-only brains show moderate pathology. The BU series documented cases of severe CTE in players who never advanced beyond high school, which complicates the neat dose-response story.

Position and impact profile matter. Linemen absorb more repetitive subconcussive loading than skill-position players, and studies of head-impact exposure at the high school level show linemen experience the highest cumulative acceleration loads. Age of first exposure is another variable: starting tackle football before age 12 has been associated in some cohort studies with earlier symptom onset, though the literature is mixed and the effect sizes modest.

Diagnostic edge cases matter for counting. CTE pathology is staged, and mild stage 1 or 2 findings in an asymptomatic young man who died of unrelated causes would count as CTE in a prevalence series but might never have affected him. Whether such incidental cases should be counted in "how common is CTE" is a live debate among neuropathologists, and it changes the answer materially.

Misconceptions worth correcting

The most common error is treating a positive headline percentage as the prevalence among all former high school players. It is not. Brain banks are selected samples of people who died, often with symptoms, and the correct reading is "prevalence among donors."

A second error is treating concussions as the causal unit. Concussion counts are a poor proxy for CTE risk because many hits produce subconcussive injury without diagnosis. Two players with the same reported concussion history can have very different cumulative exposure.

A third error is conflating CTE with Alzheimer's or with general "brain damage" from sport. The pathology differs, the symptom profiles overlap, and diagnosis requires tissue. A fourth is assuming that a living player can be tested for CTE; no validated biomarker currently does this.

Practical actions for families and programs

Red-flag warnings to treat as stop signs:

Any player with persistent headache, confusion, or mood change after a season should be evaluated by a physician, not cleared informally. A player who hides symptoms to stay in a game is at risk for repeated injury and should be removed from play. Repeated "bell-ringers" without formal evaluation are a warning pattern for cumulative exposure. Never treat an imaging scan or blood test as a CTE diagnosis; no such test exists.

Concrete steps: track cumulative seasons and impact exposure, not just diagnosed concussions. Use certified helmets and follow state return-to-play protocols. Reduce full-contact practice time where rules allow; several states cap in-season full-contact practice. Encourage any symptomatic player to see a clinician experienced in sports neurology. For families considering brain donation after a player's death, contact the NIH NeuroBioBank or a university brain bank early, since timing affects tissue quality.

Limitations of the current evidence

Every number in this article inherits the limits of its source. Brain-bank series have selection bias that likely runs in both directions, depending on donation patterns. There is no population-based denominator for CTE prevalence at any level of play. Consensus neuropathological criteria have been updated over time, meaning older prevalence figures may use different thresholds than newer ones. And the clinical significance of mild pathology in asymptomatic young people is unresolved.

What can be said with confidence is this: CTE in high school-only football players is uncommon in donated series, well below the rates reported in professional players, and no one currently knows the true population prevalence. The honest answer to the keyword question is a range tied to sample type, not a single percentage.

Comparison table: CTE in donated brains by level of play

The table below reflects published brain-bank series and illustrates the dose-response pattern. All figures describe donated samples, not general populations.

Level of play Approximate share of donated brains with CTE Caveat
High school only Roughly 3-10 percent, depending on case definition Selected, symptomatic donors
College football Higher than high school, lower than professional Smaller sample sizes
Professional football Over 60 percent in the BU series Highly selected donors
Youth football only Very low in reported series Few donations, wide uncertainty
No football exposure Rare Not zero; CTE has other causes

The trend across rows supports cumulative exposure as the main driver, but each cell carries selection bias, so the table is a directional guide, not a prevalence estimate. For families, the actionable takeaway is that risk scales with years of play and impact burden, and that reducing unnecessary full-contact exposure is the lever most within control. For researchers, the open task is a validated living biomarker, which would replace brain-bank percentages with actual population rates and finally settle how common CTE really is.